UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

First experience of the AML‐Berlin‐Frankfurt‐Münster group in pediatric patients with standard‐risk acute promyelocytic leukemia treated with arsenic trioxide and all‐trans retinoid acid

Pediatric blood & cancer, 2017-08, Vol.64 (8), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations

British journal of haematology, 2010-04, Vol.149 (1), p.84-92

2010

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups

Pediatric blood & cancer, 2017-12, Vol.64 (12), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Modulation of antigen expression in B‐cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug‐induced regulatory phenomenon. Results of the AIEOP‐BFM‐ALL‐FLOW‐MRD‐Study Group

Cytometry. Part B, Clinical cytometry, 2010-05, Vol.78B (3), p.147-153

2010

Link zum Volltext

Verfügbarkeit prüfen

The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment‐related mortality and not an increased relapse rate – a population‐based analysis of 25 years of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group

British journal of haematology, 2013-05, Vol.161 (4), p.556-565

2013

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria – A population‐based report of the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group

British journal of haematology, 2009-02, Vol.144 (4), p.559-570

2009

Link zum Volltext

Verfügbarkeit prüfen

Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B‐cell precursor acute lymphoblastic leukemia cells

Cytometry. Part B, Clinical cytometry, 2008-05, Vol.74B (3), p.150-155

2008

Link zum Volltext

Verfügbarkeit prüfen

Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups

Cancer, 2016-12, Vol.122 (24), p.3821-3830

2016

Link zum Volltext

Verfügbarkeit prüfen

Rothia mucilaginosa bacteremia: A 10‐year experience of a pediatric tertiary care cancer center

Pediatric blood & cancer, 2019-07, Vol.66 (7), p.e27691-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases

Genes chromosomes & cancer, 2006-06, Vol.45 (6), p.608-611

2006

Link zum Volltext

Verfügbarkeit prüfen

Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry

Pediatric blood & cancer, 2021-01, Vol.68 (1), p.e28706-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis

Pediatric blood & cancer, 2016-04, Vol.63 (4), p.640-645

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

Pediatric blood & cancer, 2019-10, Vol.66 (10), p.e27900-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study

British journal of haematology, 2010-03, Vol.148 (5), p.768-776

2010

Link zum Volltext

Verfügbarkeit prüfen

High hyperdiploid acute lymphoblastic leukemia (ALL)—A 25‐year population‐based survey of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group

Pediatric blood & cancer, 2017-06, Vol.64 (6), p.np-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses

British journal of haematology, 2010-05, Vol.149 (3), p.399-409

2010

Link zum Volltext

Verfügbarkeit prüfen

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible

Cytometry. Part B, Clinical cytometry, 2008-11, Vol.74B (6), p.331-340

2008

Link zum Volltext

Verfügbarkeit prüfen

Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome

Cytometry. Part B, Clinical cytometry, 2013-11, Vol.84 (6), p.370-378

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic relevance of TLX3 (HOX11L2) expression in childhood T‐cell acute lymphoblastic leukaemia treated with Berlin–Frankfurt–Münster (BFM) protocols containing early and late re‐intensification elements

British journal of haematology, 2010-01, Vol.148 (2), p.293-300

2010

Link zum Volltext

Verfügbarkeit prüfen

Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: A population-based analysis of the Austrian cooperative study group

Pediatric Blood & Cancer, 2005-01, Vol.44 (1), p.70-76

2005

Link zum Volltext

Verfügbarkeit prüfen

Nodular pulmonary lesions in children after autologous stem cell transplantation: a source of misinterpretation

British journal of haematology, 2008-02, Vol.140 (4), p.429-432

2008

Link zum Volltext

Verfügbarkeit prüfen

Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: Significance and therapy response

Medical and pediatric oncology, 2002-12, Vol.39 (6), p.558-565

2002

Link zum Volltext

Verfügbarkeit prüfen

Wilms tumor and cardiomyopathy

Medical and pediatric oncology, 2003-12, Vol.41 (6), p.574-574

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

ThemaChild, Preschool

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Child
(21)
Infant
(21)
Adolescent
(19)
Female
(19)
Male
(19)
Hematology
(16)
Oncology
(13)
Pediatrics
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Prognosis
(10)
Retrospective Studies
(9)
Treatment Outcome
(9)
Hematologic And Hematopoietic Diseases
(7)
Recurrence
(7)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(25)
Wiley Online Library Full Collection 2018
(24)
Journals@Ovid Ovid Full Text
(19)
EZB Free E-Journals
(14)
Springer Book Series
(1)
Publisher or Other Site
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

British Journal Of Haematology
(8)
Pediatric Blood & Cancer
(8)
Cytometry. Part B, Clinical Cytometry
(4)
Medical And Pediatric Oncology
(2)
Cancer
(1)
Cancer Reports
(1)
Genes Chromosomes & Cancer
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

First experience of the AML‐Berlin‐Frankfurt‐Münster group in pediatric patients with standard‐risk acute promyelocytic leukemia treated with arsenic trioxide and all‐trans retinoid acid

Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations

Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups

Modulation of antigen expression in B‐cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug‐induced regulatory phenomenon. Results of the AIEOP‐BFM‐ALL‐FLOW‐MRD‐Study Group

The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment‐related mortality and not an increased relapse rate – a population‐based analysis of 25 years of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group

Long‐term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria – A population‐based report of the Austrian Berlin‐Frankfurt‐Münster (BFM) Study Group

Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria

Prognostic relevance of dic(9;20)(p11;q13) in childhood B‐cell precursor acute lymphoblastic leukaemia treated with Berlin‐Frankfurt‐Münster (BFM) protocols containing an intensive induction and post‐induction consolidation therapy

Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B‐cell precursor acute lymphoblastic leukemia cells

Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups

Rothia mucilaginosa bacteremia: A 10‐year experience of a pediatric tertiary care cancer center

Near-tetraploidy in childhood B-cell precursor acute lymphoblastic leukemia is a highly specific feature of ETV6/RUNX1-positive leukemic cases

Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry

Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis

Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study

High hyperdiploid acute lymphoblastic leukemia (ALL)—A 25‐year population‐based survey of the Austrian ALL‐BFM (Berlin‐Frankfurt‐Münster) Study Group

Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible

Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome

Prognostic relevance of TLX3 (HOX11L2) expression in childhood T‐cell acute lymphoblastic leukaemia treated with Berlin–Frankfurt–Münster (BFM) protocols containing early and late re‐intensification elements

Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: A population-based analysis of the Austrian cooperative study group

Nodular pulmonary lesions in children after autologous stem cell transplantation: a source of misinterpretation

Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: Significance and therapy response

Wilms tumor and cardiomyopathy

Aktive Filter

Suchergebnisse filtern